Ehlers-Danlos Syndromes (EDS) Panel

Casandra

Casandra Test Code PG92648Version 1 (DRAFT)

Performing Lab

Lab Prevention GeneticsLab Test ID 10383CPT Code 81479

Ehlers-Danlos Syndromes (EDS) Panel

Clinical Use

Use

This test is intended for individuals who have clinical or suspected diagnosis of Ehlers-Danlos syndromes (EDS) or a family history of EDS or related connective tissue disorders. The analysis provides comprehensive genetic profiling to aid in the diagnosis and management of EDS by covering a wide range of genes related to connective tissue disorders.

Special Instructions

Test requisition form needs to be filled out to initiate testing. Online ordering is available through myPrevent. STAT testing is available by adding a surcharge. Please ensure all special test instructions are included in the comments section.

Limitations

These genetic tests have not been cleared or approved by the US Food and Drug Administration. Results should be interpreted in conjunction with clinical findings and other diagnostic criteria. Variants of uncertain significance may be identified, and not all benign variants will be reported.

Test Details

Methodology

NGS (CGP)

Biomarkers

This component uses next-generation sequencing with CNV analysis to examine a panel of 65 genes associated with Ehlers-Danlos syndromes and related connective tissue disorders.

NGS with CNV Analysis • CGP